Drug intelligence / Profile preview

Bioengineered Artificial Mesenchymal Sheet

Development stage
Phase 2
Modality
Tissue Cells → Other Cell Types → Cell Therapies, Stem Cell Therapies → Cell Therapies
Administration
Cutaneous, Transplantation
01

Overview

Bioengineered Artificial Mesenchymal Sheet (BAMS) is a cell-based therapeutic product designed for tissue regeneration and repair. It typically consists of mesenchymal stem cells (MSCs), often derived from adipose tissue, expanded on a biological matrix, such as fibrin-hyaluronic acid. The sheet format is engineered to preserve cell-to-cell contacts and the extracellular matrix, allowing for intact transplantation without enzymatic digestion. The therapeutic effect is primarily mediated by the MSCs' ability to secrete a wide array of paracrine factors, including growth factors and cytokines, which modulate inflammation, promote angiogenesis, stimulate tissue healing, and recruit host cells to the site of injury. This approach aims to improve cell retention and survival compared to traditional single-cell suspensions. BAMS is being investigated for various regenerative medicine applications, including the treatment of venous ulcers, corneal injuries, cartilage defects, bone regeneration, and skin wound healing.

Other names
Mesenchymal stem cell sheetMSC sheetCell sheet

Beyond the preview

Go deeper on Bioengineered Artificial Mesenchymal Sheet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioengineered Artificial Mesenchymal Sheet.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call